Related Experiment Video
Updated: Jun 2, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Structural basis of SETD6-mediated regulation of the NF-kB network via methyl-lysine signaling
Yanqi Chang1, Dan Levy, John R Horton
1Department of Biochemistry, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, USA.
Abstract:
SET domain containing 6 (SETD6) monomethylates the RelA subunit of nuclear factor kappa B (NF-κB). The ankyrin repeats of G9a-like protein (GLP) recognizes RelA monomethylated at Lys310. Adjacent to Lys310 is Ser311, a known phosphorylation site of RelA. Ser311 phosphorylation inhibits Lys310 methylation by SETD6 as well as binding of Lys310me1 by GLP. The structure of SETD6 in complex with RelA peptide containing the methylation site, in the presence of S-adenosyl-L-methionine, reveals a V-like protein structure and suggests a model for NF-κB binding to SETD6. In addition, structural modeling of the GLP ankyrin repeats bound to Lys310me1 peptide provides insight into the molecular basis for inhibition of Lys310me1 binding by Ser311 phosphorylation. Together, these findings provide a structural explanation for a key cellular signaling pathway centered on RelA Lys310 methylation, which is generated by SETD6 and recognized by GLP, and incorporate a methylation-phosphorylation switch of adjacent lysine and serine residues. Finally, SETD6 is structurally similar to the Rubisco large subunit methyltransferase. Given the restriction of Rubisco to plant species, this particular appearance of the protein lysine methyltransferase has been evolutionarily well conserved.
Insights
SET domain containing 6 (SETD6) modifies RelA, a subunit of nuclear factor kappa B (NF-κB). This methylation and phosphorylation switch regulates NF-κB signaling, with structural insights into SETD6 and GLP interactions.
Area of Science:
- Molecular Biology
- Structural Biology
- Biochemistry
Background:
- Nuclear factor kappa B (NF-κB) signaling is crucial in cellular responses.
- RelA, a key NF-κB subunit, undergoes post-translational modifications like methylation and phosphorylation.
- SET domain containing 6 (SETD6) and G9a-like protein (GLP) are involved in RelA modification.
Purpose of the Study:
- To elucidate the structural basis of RelA Lys310 methylation by SETD6.
- To understand how GLP recognizes methylated RelA.
- To investigate the inhibitory mechanism of Ser311 phosphorylation on Lys310 methylation and GLP binding.
Main Methods:
- X-ray crystallography of SETD6 complexed with a RelA peptide.
- Structural modeling of GLP ankyrin repeats with a methylated RelA peptide.
- Bioinformatic analysis of SETD6 structural similarity.
Main Results:
- The structure of SETD6 reveals a V-like protein fold and suggests a binding model for NF-κB.
- Structural modeling explains how Ser311 phosphorylation inhibits Lys310 methylation and GLP binding.
- SETD6 shares evolutionary conservation with Rubisco methyltransferases.
Conclusions:
- A structural mechanism for the methylation-phosphorylation switch at RelA Lys310/Ser311 is proposed.
- SETD6 and GLP play critical roles in regulating NF-κB signaling through RelA modification.
- The evolutionary conservation of SETD6 highlights the importance of this regulatory pathway.
More Related Videos
10:09Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Co-activators and Co-repressors
Master Transcription Regulators
The JAK-STAT Signaling Pathway